epidermolysis bullosa

3 items

December 16, 2019

Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science
– Acquisition complements and expands Castle Creek [...]
June 25, 2018

Castle Creek Pharmaceuticals Announces First Patient with Epidermolysis Bullosa Enrolled in Pharmacokinetics Study of Diacerein 1% Ointment
New multi-center Phase 1 study expected to [...]
May 16, 2018

Castle Creek Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for Diacerein 1% Ointment for Epidermolysis Bullosa
PARSIPPANY, N.J., May 16, 2018 – Castle Creek [...]